Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Bayer and Tsinghua University to Form Joint Institute

publication date: Mar 19, 2009

Bayer HealthCare AG of Germany has signed a wide-ranging collaboration agreement with Beijing’s Tsinghua University. The two entities will establish the Bayer-Tsinghua (Institute of Biomedicine) Research Center of Innovative Drug Discovery. Serving as Director will be Yigong Shi, PhD, a renowned structural biologist with expertise in protein X-ray crystallography and a focus on apoptosis. Dr. Shi is currently Director of the Department of Biological Sciences and Biotechnology and Vice Dean of the Institute of Biomedicine of Tsinghua University. More details...

Stock Symbol: (Frankfurt: SCH)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital